# Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.

> **NCT07063979** · NA · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 100 (estimated)

## Conditions studied

- Postoperative Nausea and Vomiting
- Bariatric Sleeve Gastrectomy

## Interventions

- **DEVICE:** Wearable Transcutaneous electrical Nerve Stimulation unit to mitigate postoperative nausea and vomiting (PONV) in the Bariatric Surgical Patient
- **DEVICE:** A sham device that will mimic the active wearable device. It will look the same, and buzz but will not actually admit a low-leve electric current that would stimulate the nerves.

## Key facts

- **NCT ID:** NCT07063979
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063979, "Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07063979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*